Stock listing

Fujian Haixi Pharmaceuticals Co., Ltd. Class H

Selected listing: 2637 · HKEX · HKD · HK

Fujian Haixi Pharmaceuticals Co., Ltd. Class H (HKEX:2637), Health Technology. Latest release Aug 4, 2026: Fujian Haixi Pharmaceuticals Says US FDA Approves…

2637:HKEXHKDHKUpdated October 2, 2026
Fujian Haixi Pharmaceuticals Co., Ltd. Class H logo
Ticker
HKEX:2637
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

About Fujian Haixi Pharmaceuticals Co., Ltd. Class H

Fujian Haixi Pharmaceuticals Co., Ltd. Class H, trading under the ticker 2637, is a public company listed on the Hong Kong Stock Exchange. It focuses on the pharmaceutical industry, contributing to healthcare solutions in the region.

Latest news from Fujian Haixi Pharmaceuticals Co., Ltd. Class H

Fujian Haixi Pharmaceuticals Says US FDA Approves IND Application Of HX9428

August 4, 2026

Fujian Haixi Pharmaceuticals Nominates Chen Tingze As Candidate For Executive Director

July 15, 2026

All Fujian Haixi Pharmaceuticals Co., Ltd. Class H news →

Research Fujian Haixi Pharmaceuticals Co., Ltd. Class H

Fujian Haixi Pharmaceuticals Co., Ltd. Class H company profile

View the public company page for Fujian Haixi Pharmaceuticals Co., Ltd. Class H on 6ix.

Fujian Haixi Pharmaceuticals Co., Ltd. Class H news

Read company news and market updates connected to Fujian Haixi Pharmaceuticals Co., Ltd. Class H.

Fujian Haixi Pharmaceuticals Co., Ltd. Class H investor events

Find investor webinars, events, and replay context for Fujian Haixi Pharmaceuticals Co., Ltd. Class H.